http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005058334-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5343fef423f7a45f534b872d5f32dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b356567266391a29635a37b6cd24fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cb5597d97ad088ad238ac53016bd16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b92ccf23883ec0fd84d82cddbd49229
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82B3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G23-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
filingDate 2004-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19affc92b6c7d8485a3785a577209adf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29e1c8f5186b4a8db321294ebc0e2262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5758df5e02cd0cff1a99d8d6bf60a4f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5056a94315cad2f72580fe39058d6998
publicationDate 2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005058334-A1
titleOfInvention A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
abstract A blood plasma for human use pooled from donors which belong to 10 % or more to a non-Caucasian population, the plasma obtainable by mixing blood or blood plasma of blood groups A and B, optionally AB without admixing substantial amounts of blood or blood plasma of blood group 0 characterized in that four to eight parts of blood or blood plasma from donors having the blood group A, more than three parts to seven parts of blood or blood plasma from donors having the blood group B, zero to two parts of blood or blood plasma from donors having the blood group AB.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011290609-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012022914-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2431024-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2963737-A1
priorityDate 2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9907390-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425953283
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12092
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1346520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129284969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408552
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1346520
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103

Total number of triples: 46.